Skip to content

Real-World Evidence in Patient-Reported Outcomes for Medical Cannabis (MC-RWE)

Anxiety | Epilepsy | Pain | Depression | Sleep

This prospective observational study aims to describe the effectiveness of MC on pain, epilepsy, sleep and /or anxiety/depression in a cohorts of patients authorized to use MC, using pre-defined, validated self assessment scales.

null

Conditions de participation

  • Sexe:

    ALL

  • Âges admissibles:

    19 and up

Critères de participation

Inclusion Criteria:

* Subjects (≥19 years of age) who are MC-naïve or -experienced with a medical authorization for MC provided by a prescribing health care practitioner and who have provided informed consent
* Primary therapeutic indications for MC use: pain, epilepsy, sleep, and/or anxiety/depression.
* Subjects agree to use verified products and refrain from using any other cannabis products, either medical or recreational, during the duration of the study

Exclusion Criteria:

* Concomitant use of illicit drugs
* Concomitant use of recreational cannabis

Lieu de l'étude

Toronto General Hospital, UHN
Toronto General Hospital, UHN
Toronto, Ontario
Canada

Contactez l'équipe d'étude

Backup Contact

Sonal Thaker

[email protected]
416-340-4800
Primary Contact

Jo Carroll, RN

[email protected]
416-340-4800
Étude parrainée par
University Health Network, Toronto
Participants recherchés
Plus d'informations
ID de l'étude: NCT04526093